Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (FAST TRACK)

Fundación EPIC

Status

Active, not recruiting

Conditions

Heart Valve Diseases

Aortic Valve Stenosis

Aortic Valve Disease

Treatments

Device: TF TAVI

Study type

Observational

Funder types

Other

Identifiers

EPIC19-FAST TRACK

Details and patient eligibility

About

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Full description

Evaluation of the safety and efficacy of early discharge (24 hours) after transfemoral transcatheter aortic prosthesis implantation (TAVI).

Enrollment

585 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients who meet all of the following conditions will be included:

Patients ≥ 18 years undergoing transfemoral TAVI implantation scheduled, performed on an outpatient basis.
Patients with percutaneous implant.
Patients undergoing the procedure under superficial sedation or Local anesthesia.
Patients with baseline narrow QRS that does not change after implantation, or definitive pacemaker carrier.
Patients who have signed the informed consent.

Exclusion criteria

Patients who do not meet any of the following conditions:

Patients with a wide QRS (greater than or equal to 120 msec) at baseline, with the except for patients with permanent pacemakers.
Hospitalized patients undergoing urgent TAVI implantation.
Patients with access other than percutaneous transfemoral.